Clinical Trial Update: Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

View source ↗

Summary

This completed multicenter observational trial evaluated how specific antimicrobials and minimum inhibitory concentration values affect outcomes in bloodstream …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Bloodstream Infection
• Carbapenemase-producing Enterobacteriaceae Infection
• Extended-spectrum Beta-lactamase Producing Enterobacteriaceae Infection

Snippet

Sponsor: JESUS RODRIGUEZ BAÑO | Conditions: Clinically Significant Bacteremia | Status: COMPLETED